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Background: The Intermountain Risk Score (IMRS), a sex-specific mortality-prediction metric created in a general medical population and 
validated in a variety of other populations has been shown to predict mortality. The IMRS is comprised of the components of the CBC, BMP, and age. 
Whether the addition of data from the complete metabolic panel (CMP) and CBC with differential [CBCD] improves risk stratification is unknown.
Methods: Pts with baseline CMP and CBCD measurements were randomly assigned (60%/40%) to independent training (n=60,411) and test 
(n=40,291) populations. A sex-specific risk score based on the IMRS methods was computed in the training population using adjusted multivariable 
regression weights from all significant and non-collinear CMP and CBCD components.
Results: Age averaged 67±16 yrs for females and 67±15 yrs for males. Final components from the CMP and CBCD that were included in the 
expanded IMRS included the original IMRS features and albumin, alkaline phosphatase, AST, bilirubin, protein, basophil, eosinophil, monocyte, and 
the neutrophil/lymphocyte ratio. ROC c-statistics for 30 day, 1 year, and 5 year death (Table) showed improvement in both females and males.
Conclusions: The addition of the unique CMP and CBCD components to the IMRS improved risk prediction for short, intermediate, and long-term 
mortality. These results show that the expanded IMRS should be further studied as a tool in patient care, risk-adjustment, and clinical research 
settings for predicting outcomes.
